COVID-19's hidden impact on blood clot recovery revealed
NCT ID NCT04465656
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tracked 88 adults diagnosed with pulmonary embolism (a serious blood clot in the lungs) during April 2020, the peak of the COVID-19 pandemic in France. Researchers compared complications like recurrence of clots, lung scarring, and death over 6 to 12 months between patients who had COVID-19 and those who did not. The goal was to understand how the virus affects recovery, using serology tests to confirm past infection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could clarify how COVID-19 affects recovery from pulmonary embolism, guiding future treatment.
What could go wrong
This is an observational registry with only 88 participants, so findings may not apply broadly. It does not test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Saint Joseph Marseille
Marseille, France